What is the current valuation of the South America Allergy Immunotherapy Market?

As of 2024, the market valuation was 283.0 USD Million. Read More

What is the projected market size for the South America Allergy Immunotherapy Market by 2035?

The market is expected to reach a valuation of 762.7 USD Million by 2035. Read More

What is the expected CAGR for the South America Allergy Immunotherapy Market during the forecast period?

The market is projected to grow at a CAGR of 9.43% from 2025 to 2035. Read More

Which application segment holds the highest market value in the South America Allergy Immunotherapy Market?

The Allergic Rhinitis segment had a valuation of 113.0 USD Million in 2024 and is expected to grow significantly. Read More

How does the market for Sublingual Immunotherapy compare to other types?

Sublingual Immunotherapy was valued at 80.0 USD Million in 2024, indicating strong demand compared to other types. Read More

What demographic segment is projected to dominate the South America Allergy Immunotherapy Market?

The Adult Patients segment had a valuation of 150.0 USD Million in 2024 and is likely to continue leading the market. Read More

What are the expected trends in treatment duration segments for the market?

Long-term Treatment is projected to grow from 85.0 USD Million in 2024 to a higher valuation by 2035. Read More

Which companies are key players in the South America Allergy Immunotherapy Market?

Key players include Allergopharma, Aimmune Therapeutics, Stallergenes Greer, and Merck KGaA, among others. Read More

What is the market outlook for Food Allergies in the South America Allergy Immunotherapy Market?

The Food Allergies segment was valued at 40.0 USD Million in 2024 and is expected to see growth in the coming years. Read More

How does the market for Geriatric Patients compare to other demographics?

The Geriatric Patients segment had a valuation of 40.0 USD Million in 2024, indicating a smaller market share compared to Adult Patients. Read More

South America Allergy Immunotherapy Market

ID: MRFR/HC/54530-HCR

200 Pages

Nidhi Mandole

Last Updated: May 12, 2026

South America Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies), By Patient Type (Pediatric, Adult, Geriatric) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Forecast to 2035

South America Allergy Immunotherapy Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 South America Allergy Immunotherapy Market, BY Application (USD Million) | |
  1. 4.1.1 Allergic Rhinitis | |
  2. 4.1.2 Allergic Asthma | |
  3. 4.1.3 Atopic Dermatitis | |
  4. 4.1.4 Food Allergies |
2. 4.2 South America Allergy Immunotherapy Market, BY Type of Immunotherapy (USD Million) | |
  1. 4.2.1 Subcutaneous Immunotherapy | |
  2. 4.2.2 Sublingual Immunotherapy | |
  3. 4.2.3 Oral Immunotherapy | |
  4. 4.2.4 Intranasal Immunotherapy |
3. 4.3 South America Allergy Immunotherapy Market, BY Patient Demographics (USD Million) | |
  1. 4.3.1 Pediatric Patients | |
  2. 4.3.2 Adult Patients | |
  3. 4.3.3 Geriatric Patients | |
  4. 4.3.4 Gender-based Segmentation |
4. 4.4 South America Allergy Immunotherapy Market, BY Treatment Duration (USD Million) | |
  1. 4.4.1 Short-term Treatment | |
  2. 4.4.2 Long-term Treatment | |
  3. 4.4.3 Maintenance Treatment | |
  4. 4.4.4 Induction Treatment 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the South America Allergy Immunotherapy Market | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the South America Allergy Immunotherapy Market | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Allergopharma (BR) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Aimmune Therapeutics (BR) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Stallergenes Greer (BR) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Meda Pharma (BR) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Boehringer Ingelheim (BR) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Merck KGaA (BR) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Novartis (BR) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Sanofi (BR) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Bayer (BR) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
6. 6.3 SOUTH AMERICA MARKET ANALYSIS BY TYPE OF IMMUNOTHERAPY |
7. 6.4 SOUTH AMERICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS |
8. 6.5 SOUTH AMERICA MARKET ANALYSIS BY TREATMENT DURATION |
9. 6.6 KEY BUYING CRITERIA OF SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET |
12. 6.9 DRIVERS IMPACT ANALYSIS: SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET |
14. 6.11 SUPPLY / VALUE CHAIN: SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET |
15. 6.12 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY APPLICATION, 2024 TO 2035 (USD Million) |
17. 6.14 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF IMMUNOTHERAPY, 2024 (% SHARE) |
18. 6.15 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TYPE OF IMMUNOTHERAPY, 2024 TO 2035 (USD Million) |
19. 6.16 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE) |
20. 6.17 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million) |
21. 6.18 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TREATMENT DURATION, 2024 (% SHARE) |
22. 6.19 SOUTH AMERICA ALLERGY IMMUNOTHERAPY MARKET, BY TREATMENT DURATION, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million) | |
  2. 7.2.2 BY TYPE OF IMMUNOTHERAPY, 2026-2035 (USD Million) | |
  3. 7.2.3 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million) | |
  4. 7.2.4 BY TREATMENT DURATION, 2026-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

South America Allergy Immunotherapy Market Segmentation

South America Allergy Immunotherapy Market By Application (USD Million, 2022-2035)

Allergic Rhinitis
Allergic Asthma
Atopic Dermatitis
Food Allergies

South America Allergy Immunotherapy Market By Type of Immunotherapy (USD Million, 2022-2035)

Subcutaneous Immunotherapy
Sublingual Immunotherapy
Oral Immunotherapy
Intranasal Immunotherapy

South America Allergy Immunotherapy Market By Patient Demographics (USD Million, 2022-2035)

Pediatric Patients
Adult Patients
Geriatric Patients
Gender-based Segmentation

South America Allergy Immunotherapy Market By Treatment Duration (USD Million, 2022-2035)

Short-term Treatment
Long-term Treatment
Maintenance Treatment
Induction Treatment

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓